Literature DB >> 26919866

HPV self-sampling in Japanese women: A feasibility study in a population with limited experience of tampon use.

Sharon Jb Hanley1, Hiromasa Fujita2, Susumu Yokoyama3, Shiori Kunisawa3, Akiko Tamakoshi4, Peixin Dong5, Noriko Kobayashi6, Hidemichi Watari6, Masataka Kudo6, Noriaki Sakuragi7.   

Abstract

OBJECTIVES: Cervical cancer incidence and mortality is increasing in Japanese women under age 50. Screening uptake is low and proactive recommendations for human papillomavirus vaccination have been suspended. Other cervical cancer prevention initiatives are urgently needed. We assessed whether human papillomavirus self-sampling might be an acceptable alternative to physician-led screening, particularly in women with limited experience of tampon use. We also sought to identify any practical, logistical, or safety issues in women already attending for screening, before carrying out further large-scale studies in non-responders.
METHODS: In total, 203 women aged 20-49 attending their annual workplace healthcheck in Sapporo, northern Japan, performed unsupervised human papillomavirus self-sampling before undergoing a physician-led cervical smear and human papillomavirus test, and completing a measure of acceptability for both tests.
RESULTS: Ninety per cent of participants stated they would use self-sampling again. They found instructions easy to follow and reported no issues with the usability of the self-sampling device. Compared with physician-led testing, women found self-sampling significantly less painful, less embarrassing and could relax more (p < 0.001), regardless of history of tampon use, which was associated with negative experiences in physician sampling (p = 0.034). Women lacked confidence the test had been performed correctly, despite no unsatisfactory samples. No safety issues were reported.
CONCLUSIONS: Self-sampling was highly acceptable in this population of women. They could perform the test safely unsupervised, but lacked confidence the test has been carried out correctly. Japanese women need to be educated about the accuracy of human papillomavirus self-sampling and further large-scale studies are necessary in non-responders.
© The Author(s) 2016.

Entities:  

Keywords:  Cervical cancer; acceptability; human papillomavirus self-sampling; screening; tampon use

Mesh:

Year:  2016        PMID: 26919866     DOI: 10.1177/0969141315625702

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  11 in total

1.  Acceptability of Self-Sample Human Papillomavirus Testing Among Thai Women Visiting a Colposcopy Clinic.

Authors:  Natacha Phoolcharoen; Nuttavut Kantathavorn; Wasanai Krisorakun; Chantanee Taepisitpong; Waraphorn Krongthong; Siriporn Saeloo
Journal:  J Community Health       Date:  2018-06

2.  Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2).

Authors:  Mihaela Grigore; Ingrid-Andrada Vasilache; Petru Cianga; Daniela Constantinescu; Odetta Duma; Roxana Daniela Matasariu; Ioana-Sadiye Scripcariu
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

3.  Towards the elimination of cervical cancer in Japan.

Authors:  Sharon J B Hanley
Journal:  J Gynecol Oncol       Date:  2021-07       Impact factor: 4.401

4.  HPV self-sampling for cervical cancer screening: a systematic review of values and preferences.

Authors:  Holly Nishimura; Ping Teresa Yeh; Habibat Oguntade; Caitlin E Kennedy; Manjulaa Narasimhan
Journal:  BMJ Glob Health       Date:  2021-05

5.  A single-arm study evaluating bevacizumab, cisplatin, and paclitaxel followed by single-agent bevacizumab in Japanese patients with advanced cervical cancer.

Authors:  Toru Sugiyama; Mika Mizuno; Yoichi Aoki; Manabu Sakurai; Tadaaki Nishikawa; Eisuke Ueda; Kosei Tajima; Nobuhiro Takeshima
Journal:  Jpn J Clin Oncol       Date:  2016-10-07       Impact factor: 3.019

6.  HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia.

Authors:  Eshetu Lemma Haile; Simoens Cindy; Benoy Ina; Gurja Belay; Van Geertruyden Jean-Pierre; Ransom Sharon; Lebelo Ramokone Lisbeth; Bogers Johannes Paul
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  Feasibility of HPV self-sampling pathway in Kathmandu Valley, Nepal using a human-centred design approach.

Authors:  Swastika Shrestha; Saki Thapa; Paul Sims; Andreea Ardelean; Anamika Basu; Maxine Caws; Suman Chandra Gurung; Gillian Holdsworth
Journal:  Sex Reprod Health Matters       Date:  2021

Review 8.  Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer.

Authors:  Marjolein Dieleman; Jolien de Waard; G Bea A Wisman; Ed Schuuring; Martha D Esajas; Karin M Vermeulen; Geertruida H de Bock
Journal:  Patient       Date:  2021-09-24       Impact factor: 3.883

9.  Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.

Authors:  Sharon J B Hanley; Hiromasa Fujita; Satomi Aoyama-Kikawa; Mitsunori Kasamo; Toshihiko Torigoe; Yoshihiro Matsuno; Sakuragi Noriaki
Journal:  J Gynecol Oncol       Date:  2021-11       Impact factor: 4.401

10.  Empowering Low-Income Asian American Women to Conduct Human Papillomavirus Self-Sampling Test: A Community-Engaged and Culturally Tailored Intervention.

Authors:  Grace X Ma; Lin Zhu; Shumenghui Zhai; Timmy R Lin; Yin Tan; Cicely Johnson; Carolyn Y Fang; Jerome L Belinson; Min Qi Wang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.